BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.26B |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$969M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$963M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$946M |
| 5 |
Microsoft
MSFT
|
+$803M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$219M |
| 2 |
Tesla
TSLA
|
+$156M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$147M |
| 4 |
American Tower
AMT
|
+$134M |
| 5 |
Uber
UBER
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.18% |
| 2 | Financials | 8.26% |
| 3 | Consumer Discretionary | 5.82% |
| 4 | Healthcare | 4.57% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Collegium Pharmaceutical
COLL
$913M
| $157K | ﹤0.01% |
6,626
-401
| -6% | -$9.53K |
|
3027
Ocular Therapeutix
OCUL
$2.25B
| $157K | ﹤0.01% |
9,563
-3,806
| -28% | -$73.3K |
|
3028
RPC Inc
RES
$1.4B
| $156K | ﹤0.01% |
28,963
+16,086
| +125% | +$81.6K |
|
|
VRAY
3029
DELISTED
ViewRay, Inc.
VRAY
| $156K | ﹤0.01% |
35,823
+14,783
| +70% | +$71.8K |
|
|
CNST
3030
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $155K | ﹤0.01% |
6,618
+3,278
| +98% | +$99.3K |
|
|
SRDX
3031
DELISTED
Surmodics
SRDX
| $155K | ﹤0.01% |
2,757
-28,936
| -91% | -$1.44M |
|
|
CDMO
3032
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $155K | ﹤0.01% |
8,478
-4,133
| -33% | -$68.7K |
|
3033
Caesarstone
CSTE
$104M
| $154K | ﹤0.01% |
11,246
+4,411
| +65% | +$58.4K |
|
3034
PUT
Plug Power
PLUG
$3.21B
| $154K | ﹤0.01% |
+43
| New | +$2.22K |
|
3035
IDT Corp
IDT
$1.63B
| $154K | ﹤0.01% |
6,787
-188
| -3% | -$3.36K |
|
3036
Innoviva
INVA
$1.5B
| $152K | ﹤0.01% |
12,742
-96,886
| -88% | -$1.17M |
|
3037
West Bancorporation
WTBA
$511M
| $152K | ﹤0.01% |
6,309
+2,394
| +61% | +$54.5K |
|
3038
El Pollo Loco
LOCO
$463M
| $152K | ﹤0.01% |
9,411
+4,604
| +96% | +$88K |
|
3039
Regis Corp
RGS
$69.3M
| $151K | ﹤0.01% |
603
+128
| +27% | +$28K |
|
3040
Entravision Communication
EVC
$820M
| $151K | ﹤0.01% |
37,435
+10,133
| +37% | +$35K |
|
|
ZEUS
3041
DELISTED
Olympic Steel
ZEUS
| $151K | ﹤0.01% |
5,132
+2,064
| +67% | +$40K |
|
3042
State Street SPDR S&P Pharmaceuticals ETF
XPH
$511M
| $151K | ﹤0.01% |
3,000
| – | – |
|
3043
FRP Holdings
FRPH
$425M
| $150K | ﹤0.01% |
6,100
+2,890
| +90% | +$68.1K |
|
3044
Citizens & Northern Corp
CZNC
$466M
| $150K | ﹤0.01% |
6,309
+2,780
| +79% | +$60.2K |
|
|
UMH
3045
UMH Properties
UMH
$1.39B
| $150K | ﹤0.01% |
7,825
+844
| +12% | +$14.2K |
|
3046
Select Water Solutions
WTTR
$2.73B
| $150K | ﹤0.01% |
30,098
+19,365
| +180% | +$113K |
|
3047
nLIGHT
LASR
$3.06B
| $150K | ﹤0.01% |
4,621
-2,215
| -32% | -$78.4K |
|
|
ADVM
3048
DELISTED
Adverum Biotechnologies
ADVM
| $149K | ﹤0.01% |
1,515
+385
| +34% | +$46.2K |
|
3049
Krystal Biotech
KRYS
$9.72B
| $149K | ﹤0.01% |
1,937
+20
| +1% | +$1.45K |
|
|
KDMN
3050
DELISTED
Kadmon Holdings, Inc.
KDMN
| $149K | ﹤0.01% |
38,248
+20,215
| +112% | +$92.6K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2021 Portfolio in Review
As of Q1 2021, BNP Paribas Financial Markets held 4,269 positions worth $68.3B, up 27% from $53.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets deployed $15.9B of net new capital in Q1 2021, opening 125 new positions and adding to 2,252 existing holdings. Its largest new stake was State Street SPDR S&P Homebuilders ETF: 612,151 shares worth $43.1M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 8.2% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Home Depot, an estimated $219M trimmed.
- BNP Paribas Financial Markets's largest Q1 2021 buy was State Street SPDR S&P Homebuilders ETF: 612,151 shares worth $43.1M.
- BNP Paribas Financial Markets added most to Apple in Q1 2021, an estimated $1.26B increase.
- BNP Paribas Financial Markets's biggest Q1 2021 reduction was Home Depot, cutting an estimated $219M.
- BNP Paribas Financial Markets fully exited Lumen in Q1 2021, selling an estimated $9.65M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $68.3B portfolio in Q1 2021.
- BNP Paribas Financial Markets opened 125 new positions and closed 272 in Q1 2021.
- BNP Paribas Financial Markets's portfolio value rose 27% quarter-over-quarter to $68.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2021, filed 7 May 2021.